Cite
MLA Citation
Maria Vittoria Dieci et al.. “Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.” Seminars in cancer biology, vol. 52, n.d., pp. 16–25. http://access.bl.uk/ark:/81055/vdc_100068799314.0x000018